Best practice to advance the #stemcell pipeline through mutually beneficial partnerships

Ram Mandalam, President & CEO at Cellerant Therapeutics spoke last week at the World Stem Cells & Regenerative Medicine Congress about best practice in advancing the stem cell pipeline through mutually beneficial partnerships. For example adopting innovative collaborative strategies to develop a multi used product in connection with the unmet need presented by neutropenia, which may be induced by chemotherapy or, indeed, radiation exposure.  This makes it of interest to defence departments, and budgets.

Check back here in a couple of days for the full presentation.

Leave a Reply

Your email address will not be published. Required fields are marked *